最後更新：2026年10月1日
神經性疼痛是因神經系統損傷或功能異常引起的慢性疼痛，與組織損傷性疼痛機制不同。犬貓可因椎間盤疾病、外傷、手術後神經損傷或腫瘤壓迫而發生。需要特殊的藥物管理策略。
貓的疾病表現常較犬隱匿，需注意細微行為變化
可點的項目會開啟該疾病頁。要依症狀與檢驗排出完整清單，請用鑑別診斷工具。
丁基原啡因。Analgesic
納布啡。Opioid analgesic (Agonist-antagonist)
加巴噴丁。Gabapentinoid (Anticonvulsant / Analgesic)
建議：依臨床狀況調整
| 藥物 | 劑量 | 頻率 | 路徑 | 優先級 |
|---|---|---|---|---|
| Buprenorphine Hydrochloride 丁基原啡因。Analgesic | 犬 0.01-0.02 mg/kg q6-12h IV/IM；貓 0.01-0.03 mg/kg q6-12h IV/IM | Q6-12H | IV | 首選 |
| Nalbuphine 納布啡。Opioid analgesic (Agonist-antagonist) | 犬 0.1-0.5 mg/kg q4-6h IV/IM/SC；貓 0.05-0.2 mg/kg q4-6h IV/IM/SC | Q4-6H | IV | 首選 |
| 藥物 | 劑量 | 頻率 | 優先級 |
|---|---|---|---|
| Co-danthramer, Co-danthrusate 丹蒽醌複方。Antibacterial | 犬 10-20 mg/kg q12h PO；貓 10-15 mg/kg q12h PO | Q12H | 首選 |
| Gabapentin 加巴噴丁。Gabapentinoid (Anticonvulsant / Analgesic) | 犬 5-10 mg/kg q8-12h PO；貓 5-10 mg/kg q8-12h PO | Q8-12H | 首選 |
監測頻率：依病因
[1]Modulating neuroplasticity for chronic pain relief: noninvasive neuromodulation as a promising approach.
[2]Indirect Comparison of 10 kHz Spinal Cord Stimulation (SCS) versus Traditional Low-Frequency SCS for the Treatment of Painful Diabetic Neuropathy: A Systematic Review of Randomized Controlled Trials.
[3]Neuropathic pain in cats: Mechanisms and multimodal management.
[4]Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses.
[5]AAHA Senior Care Guidelines for Dogs and Cats
需系統性診斷與治療計畫，延遲可能影響預後 (systematic workup needed, delay may affect prognosis)
視病因而定。Gabapentin 為首選藥物。多數可有效控制疼痛改善生活品質。完全消除疼痛可能困難，管理目標為可接受的疼痛程度。
Diagnostic Approach for Neuropathic Pain
Thorough history collection; complete physical examination with attention to presenting complaint
CBC, serum chemistry panel, urinalysis; additional tests based on clinical findings
Advanced imaging, specialized testing, or referral based on minimum database findings